[Fundamental and clinical studies on T-1982 (cefbuperazone) in the field of obstetrics and gynecology].
Fundamental and clinical studies on T-1982 (cefbuperazone), a new cephamycin antibiotic, were carried out in the field of obstetrics and gynecology, and the following results were obtained. In a fundamental study, T-1982 was given to 7 patients with postpanhysterectomy at a dose of 1 g by intravenous drip infusion, and T-1982 concentrations in uterine artery and elbow vein serum and each uterine tissue (fallopian tube, ovary, endometrium, corpus uteri, cervix uteri and portio) were serially determined. The concentration in the endometrium (though the range of values was wide) was found higher than that in the other tissues. In a clinical study, T-1982 was given to 5 patients; 2 patients with parametritis and each one patient with right salpingitis, pyometra and metroendometritis. The efficacy rate was 80%. No side effects nor remarkable abnormalities in hematology, urinalysis and renal and hepatic function were observed during the therapy.
D000038:Abscess / Q000188:drug therapy; D000328:Adult; D000368:Aged; D002513:Cephamycins / Q000378:metabolism* / Q000627:therapeutic use; D004716:Endometritis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy; D014599:Uterus / Q000378:metabolism
D002513:Cephamycins; C035978:cefbuperazone